123 related articles for article (PubMed ID: 29866006)
1. Hepatitis B Antigen Loaded Biodegradable Polymeric Nanoparticles: Formulation Optimization and In-vivo Immunization in BALB/c Mice.
Dewangan HK; Singh S; Maurya L; Srivastava A
Curr Drug Deliv; 2018; 15(8):1204-1215. PubMed ID: 29866006
[TBL] [Abstract][Full Text] [Related]
2. Rational design and evaluation of HBsAg polymeric nanoparticles as antigen delivery carriers.
Dewangan HK; Pandey T; Maurya L; Singh S
Int J Biol Macromol; 2018 May; 111():804-812. PubMed ID: 29343454
[TBL] [Abstract][Full Text] [Related]
3. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
[TBL] [Abstract][Full Text] [Related]
4. M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.
Gupta PN; Khatri K; Goyal AK; Mishra N; Vyas SP
J Drug Target; 2007 Dec; 15(10):701-13. PubMed ID: 18041638
[TBL] [Abstract][Full Text] [Related]
5. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
Jaganathan KS; Vyas SP
Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
[TBL] [Abstract][Full Text] [Related]
6. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
Singh D; Somani VK; Aggarwal S; Bhatnagar R
Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.
Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR
J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241
[TBL] [Abstract][Full Text] [Related]
8. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
[TBL] [Abstract][Full Text] [Related]
10. Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant.
Khademi F; Sahebkar A; Fasihi-Ramandi M; Taheri RA
APMIS; 2018 Jun; 126(6):509-514. PubMed ID: 29924445
[TBL] [Abstract][Full Text] [Related]
11. Adjuvanticity Regulation by Biodegradable Polymeric Nano/microparticle Size.
Jia J; Zhang W; Liu Q; Yang T; Wang L; Ma G
Mol Pharm; 2017 Jan; 14(1):14-22. PubMed ID: 28043126
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
Prego C; Paolicelli P; Díaz B; Vicente S; Sánchez A; González-Fernández A; Alonso MJ
Vaccine; 2010 Mar; 28(14):2607-14. PubMed ID: 20096389
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenicity of single-dose HBsAg-PLGA controlled release microspheres in mice].
Feng L; Zhou XJ; Wang SC; Jiang Y; Qi XR
Yao Xue Xue Bao; 2006 Feb; 41(2):132-7. PubMed ID: 16671543
[TBL] [Abstract][Full Text] [Related]
14. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.
Thomas C; Rawat A; Hope-Weeks L; Ahsan F
Mol Pharm; 2011 Apr; 8(2):405-15. PubMed ID: 21189035
[TBL] [Abstract][Full Text] [Related]
15. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
Tafaghodi M; Eskandari M; Kharazizadeh M; Khamesipour A; Jaafari MR
Trop Biomed; 2010 Dec; 27(3):639-50. PubMed ID: 21399606
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles.
Liu L; Ma P; Wang H; Zhang C; Sun H; Wang C; Song C; Leng X; Kong D; Ma G
J Control Release; 2016 Mar; 225():230-9. PubMed ID: 26826307
[TBL] [Abstract][Full Text] [Related]
17. PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.).
Fredriksen BN; Grip J
Vaccine; 2012 Jan; 30(3):656-67. PubMed ID: 22100638
[TBL] [Abstract][Full Text] [Related]
18. Early immune responses in Atlantic salmon (Salmo salar L.) after immunization with PLGA nanoparticles loaded with a model antigen and β-glucan.
Fredriksen BN; Sævareid K; McAuley L; Lane ME; Bøgwald J; Dalmo RA
Vaccine; 2011 Oct; 29(46):8338-49. PubMed ID: 21888940
[TBL] [Abstract][Full Text] [Related]
19. Sub-unit vaccine against S. aureus-mediated infections: set-up of nano-sized polymeric adjuvant.
Colonna C; Dorati R; Conti B; Caliceti P; Genta I
Int J Pharm; 2013 Aug; 452(1-2):390-401. PubMed ID: 23707885
[TBL] [Abstract][Full Text] [Related]
20. Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines.
Xu P; Tang S; Jiang L; Yang L; Zhang D; Feng S; Zhao T; Dong Y; He W; Wang R; Zhang J; Liang Z
J Control Release; 2016 Mar; 225():252-68. PubMed ID: 26826303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
